Abstract
Treatment of patients with unresectable stage Ilia and IIIB non-small cell lung cancer with conventional radiation therapy has resulted in poor local control, a high rate of systemic failure, and 5-year survival of less than 10%. Recent modification in radiation treatment planning, dose delivery, and fractionization has demonstrated significantly improved median and 2- year survival, comparable in some trials to that achieved with induction chemotherapy followed by radiation. Current trials focus on combining systemic therapy with dose-intense radiation therapy to improve with local and systemic control.
Original language | English (US) |
---|---|
Pages (from-to) | 423-428 |
Number of pages | 6 |
Journal | Seminars in Oncology |
Volume | 24 |
Issue number | 4 |
State | Published - 1997 |
All Science Journal Classification (ASJC) codes
- Hematology
- Oncology